Universität zu Köln

Galldiks, Norbert ORCID: 0000-0002-2485-1796, Albert, Nathalie L., Sommerauer, Michael, Grosu, Anca L., Ganswindt, Ute ORCID: 0000-0003-4492-614X, Law, Ian ORCID: 0000-0001-9644-7496, Preusser, Matthias ORCID: 0000-0003-3541-2315, Le Rhun, Emilie ORCID: 0000-0002-9408-3278, Vogelbaum, Michael A., Zadeh, Gelareh, Dhermain, Frederic, Weller, Michael ORCID: 0000-0002-1748-174X, Langen, Karl-Josef ORCID: 0000-0003-1101-5075 and Tonn, Joerg C. (2017). PET imaging in patients with meningioma-report of the RANO/PET Group. Neuro-Oncology, 19 (12). S. 1576 - 1588. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Full text not available from this repository.

Abstract

Meningiomas are the most frequent nonglial primary brain tumors and represent about 30% of brain tumors. Usually, diagnosis and treatment planning are based on neuroimaging using mainly MRI or, rarely, CT. Most common treatment options are neurosurgical resection and radiotherapy (eg, radiosurgery, external fractionated radiotherapy). For follow-up after treatment, a structural imaging technique such as MRI or CT is used. However, these structural imaging modalities have limitations, particularly in terms of tumor delineation as well as diagnosis of posttherapeutic reactive changes. Molecular imaging techniques such as PET can characterize specific metabolic and cellular features which may provide clinically relevant information beyond that obtained from structural MR or CT imaging alone. Currently, the use of PET in meningioma patients is steadily increasing. In the present article, we provide recommendations for the use of PET imaging in the clinical management of meningiomas based on evidence generated from studies being validated by histology or clinical course.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Galldiks, Norbert UNSPECIFIED orcid.org/0000-0002-2485-1796 UNSPECIFIED Albert, Nathalie L. UNSPECIFIED UNSPECIFIED UNSPECIFIED Sommerauer, Michael UNSPECIFIED UNSPECIFIED UNSPECIFIED Grosu, Anca L. UNSPECIFIED UNSPECIFIED UNSPECIFIED Ganswindt, Ute UNSPECIFIED orcid.org/0000-0003-4492-614X UNSPECIFIED Law, Ian UNSPECIFIED orcid.org/0000-0001-9644-7496 UNSPECIFIED Preusser, Matthias UNSPECIFIED orcid.org/0000-0003-3541-2315 UNSPECIFIED Le Rhun, Emilie UNSPECIFIED orcid.org/0000-0002-9408-3278 UNSPECIFIED Vogelbaum, Michael A. UNSPECIFIED UNSPECIFIED UNSPECIFIED Zadeh, Gelareh UNSPECIFIED UNSPECIFIED UNSPECIFIED Dhermain, Frederic UNSPECIFIED UNSPECIFIED UNSPECIFIED Weller, Michael UNSPECIFIED orcid.org/0000-0002-1748-174X UNSPECIFIED Langen, Karl-Josef UNSPECIFIED orcid.org/0000-0003-1101-5075 UNSPECIFIED Tonn, Joerg C. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-210365
DOI:	10.1093/neuonc/nox112
Journal or Publication Title:	Neuro-Oncology
Volume:	19
Number:	12
Page Range:	S. 1576 - 1588
Date:	2017
Publisher:	OXFORD UNIV PRESS INC
Place of Publication:	CARY
ISSN:	1523-5866
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language POSITRON-EMISSION-TOMOGRAPHY; TARGET VOLUME DELINEATION; NEUTRON-CAPTURE THERAPY; STEREOTACTIC RADIOTHERAPY; GA-68-DOTATOC PET/CT; RADIONUCLIDE THERAPY; F-18-FDG PET; LOW-GRADE; INTRACRANIAL MENINGIOMAS; SOMATOSTATIN RECEPTORS Multiple languages Oncology; Clinical Neurology Multiple languages
Refereed:	Yes
URI:	http://kups.ub.uni-koeln.de/id/eprint/21036